172 related articles for article (PubMed ID: 2661988)
21. [Thymopentin as adjuvant therapy in the hepatitis B vaccination of non- or hyporesponsive subjects].
Fuliano P; Fontana L; Bigolari M; Bovone U; Orengo G; Astengo F
Minerva Med; 1990 May; 81(5):407-13. PubMed ID: 2198499
[TBL] [Abstract][Full Text] [Related]
22. Immunomodulation in infection caused by human immunodeficiency virus.
Phair JP
J Lab Clin Med; 1989 Feb; 113(2):135-6. PubMed ID: 2644386
[No Abstract] [Full Text] [Related]
23. Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritis.
Malaise M; Franchimont P; Hauwaert C; Danneskiold-Samsoe B; Gross D; Gerber H; Gerschpacher H; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():87-93. PubMed ID: 3898298
[TBL] [Abstract][Full Text] [Related]
24. Influence of thymopentin on postsurgical immune deficiency: a clinical pilot study.
Faist E; Riedel A; Bolla K
Int J Clin Pharmacol Res; 1987; 7(1):83-7. PubMed ID: 3294617
[TBL] [Abstract][Full Text] [Related]
25. [Treatment with thymopentine of chronic bronchitis in elderly patients during seasonal prophylaxis].
Santagata A
Clin Ter; 1990 Feb; 132(4):249-54. PubMed ID: 2140311
[TBL] [Abstract][Full Text] [Related]
26. Thymopentin treatment of herpes simplex infections. An open, monitored, multicenter study.
DeMaubeuge J; Haneke E; Djawari D; Wolff K; Stingl G; Molin L; Schöpf E; Stengel R; Degreef H; Panconesi E
Surv Immunol Res; 1985; 4 Suppl 1():30-6. PubMed ID: 2863860
[TBL] [Abstract][Full Text] [Related]
27. First observations on high-dosed and long-term thymopentin treatment in active rheumatoid arthritis.
Molin L; Schmid F; Bolla K
Int J Clin Pharmacol Res; 1984; 4(6):445-9. PubMed ID: 6398313
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of cellular function by thymopentin (TP-5) in three AIDS patients.
Mascart-Lemone F; Huygen K; Clumeck N; Brenez D; Bolla K; Duchateau J
Lancet; 1983 Sep; 2(8352):735-6. PubMed ID: 6193382
[No Abstract] [Full Text] [Related]
29. Thymopentin (TP-5) therapy during lymphadenopathy syndrome (LAS/ARC): preliminary report.
Costigliola P; Ricchi E; Colangeli V; Pintori C; Boni P; Chiodo F
J Exp Pathol; 1987; 3(4):705-12. PubMed ID: 3331653
[TBL] [Abstract][Full Text] [Related]
30. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
[No Abstract] [Full Text] [Related]
31. Thymopentin in the treatment of severe alopecia areata.
Tosti A; Manuzzi P; Gasponi A
Dermatologica; 1988; 177(3):170-4. PubMed ID: 3049174
[TBL] [Abstract][Full Text] [Related]
32. Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy.
Barcellini W; Meroni PL; Frasca D; Sguotti C; Borghi MO; Uberti-Foppa C; Buzzetti P; Lazzarin A; Doria G; Moroni M
Clin Exp Immunol; 1987 Mar; 67(3):537-43. PubMed ID: 3301099
[TBL] [Abstract][Full Text] [Related]
33. Immunologic effects of long-term thymopentin treatment in patients with HIV-induced lymphadenopathy syndrome.
Silvestris F; Gernone A; Frassanito MA; Dammacco F
J Lab Clin Med; 1989 Feb; 113(2):139-44. PubMed ID: 2644387
[TBL] [Abstract][Full Text] [Related]
34. The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections.
Haneke E; Bolla K; Degreef H; Djawari D; Demaubeuge J; Molin L; Panconesi E; Schöpf E; Stengel R; Stingl G
Int J Clin Pharmacol Res; 1984; 4(6):439-43. PubMed ID: 6085327
[TBL] [Abstract][Full Text] [Related]
35. Thymopentin in experimental and clinical medicine.
Surv Immunol Res; 1985; 4 Suppl 1():1-156. PubMed ID: 3898279
[No Abstract] [Full Text] [Related]
36. [Use of thymopentin in the therapy of recurrent oral ulcers].
Robotti MP; Fabbri G; Baldin C; Faccioli G; Ciaffoni S
Minerva Stomatol; 1988 Jun; 37(6):497-503. PubMed ID: 3050443
[No Abstract] [Full Text] [Related]
37. [Thymopentin in the treatment of cutaneous melanoma].
Trevisan G; Agolzer A
G Ital Dermatol Venereol; 1989 May; 124(5):245-9. PubMed ID: 2695455
[TBL] [Abstract][Full Text] [Related]
38. [Thymic hormone treatment of acute and chronic respiratory infections in the elderly].
Agostinelli M; Zaia AM; Fiorentini A; Stecconi R; Fabris N; Scalise G
Recenti Prog Med; 1989; 80(7-8):438-41. PubMed ID: 2682857
[TBL] [Abstract][Full Text] [Related]
39. Thymopentin treatment in genital warts of long duration.
Fransen L; Anthoons J; Hoogewijs G; Bolla K
Cancer Detect Prev; 1988; 12(1-6):503-9. PubMed ID: 3052838
[TBL] [Abstract][Full Text] [Related]
40. Thymopentin treatment in a patient with pluriorificial pyoderma vegetans.
Simon M; Djawari D; Horstein OP; Bolla K
Surv Immunol Res; 1985; 4 Suppl 1():125-8. PubMed ID: 3898284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
